Infectious Diseases and International Medicine

Are you a healthy adult who is planning to receive a vaccination for yellow fever? This study may be for you! We are seeking to understand why vaccines work differently in some places and people than others. You may be compensated $2,300 for your time. For more information, visit: https://z.umn.edu/yellow-fever-vaccine-study

COVID-19 News

COVID

  • Treatment & Clinical Trials
  • In the News
  • Current Research
  • Archive: News ∙ Clinical Trials
  • Treatment & Clinical Trials

    • PREVENT COVID U COVID-19 Vaccination & Transmission Study (CoVPN 3006)
      Dr. Susan Kline and the Department of Medicine is partnering with The COVID-19 Prevention Network (CoVPN) to conduct a research study to learn whether the Moderna COVID-19 vaccine stops the spread of the SARS-CoV-2 virus: both initial infection and transmission. We already know that the Moderna vaccine can prevent serious COVID-19 disease, but we do not know if the vaccine will prevent the spread of the virus and stop transmission to others. This study will answer those questions.

    • Jo-Anne H. Young (co-author George R. Thompson, III, M.D.) was published in the New England Journal of Medicine for her publication "Aspergillus Infections"

    • Phase 3 Prevention Trial showed 81% reduced risk of symptomatic SARS-COV-2 infections with subcutaneous administration of REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB). University of Minnesota Medical School, Site Investigators: Dr. Anne-Marie Leuck, Dr. Mahsa Abassi, Dr. Matthew Pullen | View Press Release
    • Dr. Susan Kline, Principal Investigator, is Enrolling volunteers for Phase 3 Study of NVX-CoV2373 Vaccine. Learn More
    • Has someone in your household recently been diagnosed with COVID-19? Volunteer for a Clinical Trial. University of Minnesota is enrolling volunteers in a research study for individuals living with someone who recently tested positive for COVID-19. Learn More 
    • Dr. David Boulware's hydroxychloroquine trial on early outpatient treatment of COVID-19 has been published in the Annals of Internal Medicine. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
    • Dr. David Boulware discusses his Hydroxychloroquine trial on Open Forum Infectious Diseases podcast. How to Conduct a Clinical Trial During a Pandemic
  • In the News

  • Current Research

  • Archive: News ∙ Clinical Trials

About our Division

  • Talented Faculty
  • Research
  • Opportunities for Fellows
  • Think & Act Globally
  • Talented Faculty

    Talented Faculty

    The Division of Infectious Diseases and International Medicine (IDIM) has more than 50 faculty overseeing programs in clinical care, education, and research at five teaching hospitals affiliated with the University of Minnesota Medical School: University of Minnesota Medical Center (UMMC), Minneapolis VA Health Care System, Hennepin County Medical Center, Regions Hospital, and Abbott Northwestern Hospital.

    Each of these institutions serves somewhat different patient populations, and the clinical and research programs at these sites together with opportunities in global health, provide a remarkable breadth of expertise and academic experiences for trainees in the IDIM Division.

  • Research

    Research & Collaboration

    In addition to our clinical scholars and physician scientists with clinical responsibilities, five full-time research faculty contribute importantly to the research mission of our division. The Center for Infectious Diseases and Microbiology Translational Research, an interdisciplinary research center, is the base of operation for these faculty members. Epidemiological research is carried out with colleagues in the School of Public Health, which helps administrate the division’s NIH-funded MPH/MSc-related training program. The Division also benefits from collaborations with faculty members who hold joint academic appointments in other departments, colleagues in the Center for Infectious Diseases Research and Policy, the College of Veterinary Medicine, the Minnesota Department of Health, and a number of community-based Infectious Diseases faculty.

  • Opportunities for Fellows

    Opportunities for Fellows

    During their research training, Infectious Diseases Fellows can enter an NIH-supported epidemiology (MPH)/clinical research (MSc) pathway coordinated by the School of Public Health, or they can select a laboratory-based research project at several training sites, including the Center for Translational Research in Microbiology and Infectious Diseases.

  • Think & Act Globally

    Think & Act Globally

    Because of a large influx of immigrants to Minnesota and increasing challenges from emerging infections here and abroad, especially in developing countries, our goal is to: "Think and act locally and globally."

ID Intercity Clinical Case Conference

About this Conference

The ID Intercity Clinical Case Conference is a regularly scheduled didactic session, sponsored by the Infectious Diseases Division in the Department of Medicine. Presenters are invited from the University of Minnesota, the Minnesota Department of Health and the ID community.

Held weekly on Tuesday mornings throughout the year (with the exception of July), case presentations are interactive and frequently presented as “unknowns,” encouraging discovery and participation with the audience in diagnosis and treatment remedies. Fellows, residents, students, faculty and members of the ID community all present and participate. This series is open to the public and sessions are streamed live and often recorded.

Dr. Jo-Anne Young is the conference director and Betsy Wehrwein is the organizer. For further information, please contact id-ed@umn.edu.

Conference Schedule and Recordings